{"label_logits": [6.246853351593018, 0.4552418887615204, -12.85860538482666], "label_probs": [0.9969562292098999, 0.0030437649693340063, 5.02667241164545e-09], "claim": "A subclass of anti-nuclear antibodies are are anti-centromere antibodies.", "premise_source_doc_id": "Anti-nuclear_antibody", "premise_source_doc_line_num": 5, "premise_source_doc_sentence": "There are many subtypes of ANAs such as anti-Ro antibodies , anti-La antibodies , anti-Sm antibodies , anti-nRNP antibodies , anti-Scl-70 antibodies , anti-dsDNA antibodies , anti-histone antibodies , antibodies to nuclear pore complexes , anti-centromere antibodies and anti-sp100 antibodies ."}
{"label_logits": [0.34485623240470886, -0.5232188105583191, -1.9157495498657227], "label_probs": [0.6561481356620789, 0.27542394399642944, 0.0684279128909111], "claim": "A subclass of anti-nuclear antibodies are are anti-centromere antibodies.", "premise_source_doc_id": "Anti-glycoprotein-210_antibodies", "premise_source_doc_line_num": 10, "premise_source_doc_sentence": "While patients with AGPA progress toward end-stage liver failure , patients with anti-centromere antibodies often progress toward portal hypertension , further indicating a specific role of the AGPA in PBC ."}
